Dyadic Applied BioSolutions expands collaboration with Fermbox Bio.
ByAinvest
Wednesday, Dec 17, 2025 7:24 am ET1min read
DYAI--
Dyadic Applied BioSolutions has expanded its collaboration with Fermbox Bio, a biotech research & manufacturing company. The agreement enables Fermbox to manufacture and commercialize an expanding portfolio of Dyadic-developed proteins and enzymes using the Dapibus and C1 expression systems. Dyadic will co-commercialize these products, broadening the range of products, platforms, and commercial opportunities for both companies. This partnership builds on their longstanding relationship and aims to deliver sustainable bio-based products through precision fermentation and advanced biotechnology tools.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet